Topotecan is a potent inhibitor of SUMOylation in glioblastoma multiforme and alters both cellular replication and metabolic programming

Protein SUMOylation is a dynamic post-translational modification shown to be involved in a diverse set of physiologic processes throughout the cell. SUMOylation has also been shown to play a role in the pathobiology of myriad cancers, one of which is glioblastoma multiforme (GBM). As such, the clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernstock, Joshua D., Ye, Daniel, Gessler, Florian A., Lee, Yang-ja, Peruzzotti-Jametti, Luca, Baumgarten, Peter, Johnson, Kory R., Maric, Dragan, Yang, Wei, Kögel, Donat, Pluchino, Stefano, Hallenbeck, John M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547153/
https://www.ncbi.nlm.nih.gov/pubmed/28785061
http://dx.doi.org/10.1038/s41598-017-07631-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547153/
https://www.ncbi.nlm.nih.gov/pubmed/28785061
http://dx.doi.org/10.1038/s41598-017-07631-9

Ejemplares similares